Objective: To investigate the association between the basic and clinical characteristics of patients with type 2 diabetes mellitus (T2DM) and their susceptibility to Klebsiella pneumoniae colonization (KPC). Additionally, a clinical prediction model was developed to identify high-risk patients for KPC.
Methods: Data from 486 T2DM patients who visited Shanghai Fifth People's Hospital from December 2020 to December 2022 were retrospectively collected. Patients were classified into the KPC group and normal group based on their Klebsiella pneumoniae test results. Differences between the two groups were analyzed using t-test and chi-square test. Logistic regression was performed to identify factors influencing KPC susceptibility in T2DM patients, with odds ratios (ORs) calculated. A clinical prediction model was constructed using a nomogram and evaluated through the area under the receiver operating characteristic (ROC) curve (AUC), Hosmer-Lemeshow test, calibration curve, and decision curve analysis (DCA).
Results: Of the 486 T2DM patients, 124 were found to have KPC, with a colonization rate of 25.51%. Logistic regression analysis revealed that hospitalization within the past six months, elevated white blood cell count, decreased hemoglobin, and elevated ferritin levels were independent risk factors for KPC. Thyroid and liver function indicators were also associated with KPC susceptibility. The clinical prediction model achieved an AUC of 0.74 (95% CI: 0.68-0.80). The calibration curve indicated no significant differences between observed and predicted values, suggesting that the model effectively identifies high-risk KPC patients.
Conclusion: T2DM patients are at an increased risk of secondary KPC. Identifying key risk factors for KPC in T2DM patients has significant clinical implications for early identification, targeted interventions, and individualized treatment strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733326 | PMC |
http://dx.doi.org/10.62347/DZKV8669 | DOI Listing |
Diabetol Int
January 2025
Division of Diabetes and Metabolic Diseases, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo 173-8610 Japan.
Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now widely used for treating type 2 diabetes mellitus (T2DM) and obesity. We examined their association with acetonemic vomiting, especially when given to patients with low body weight, in hopes of achieving early recognition of this complication which is potentially life-threatening if not dealt with appropriately.
Methods: Cases identified incidentally are described and discussed referring to prior reports.
Front Immunol
January 2025
Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, China.
Background: Type 2 Diabetes Mellitus (T2DM) represents a major global health challenge, marked by chronic hyperglycemia, insulin resistance, and immune system dysfunction. Immune cells, including T cells and monocytes, play a pivotal role in driving systemic inflammation in T2DM; however, the underlying single-cell mechanisms remain inadequately defined.
Methods: Single-cell RNA sequencing of peripheral blood mononuclear cells (PBMCs) from 37 patients with T2DM and 11 healthy controls (HC) was conducted.
Belitung Nurs J
January 2025
University of Virginia, School of Nursing, Charlottesville, Virginia, United States.
Background: Sociocultural and behavioral factors have a multifaceted impact on maternal health. In Thailand, cultural influences significantly shape behaviors of diabetes self-management in women. However, the experience of self-managing diabetes in pregnant women with preexisting Type 2 Diabetes Mellitus (T2DM) remains unclear.
View Article and Find Full Text PDFJ Med Life
December 2024
Department of Population Health, School of Health Sciences, Hofstra University, Hempstead, New York, USA.
This study explored the role of dentate status and dental caries on diabetes-related complications among patients with type 2 diabetes mellitus (T2DM). A hospital-based cross-sectional design was applied to collect data on diabetic patients attending integrated services for non-communicable diseases and oral health at a public hospital in Thailand. Diabetic complication outcomes included diabetic eye and foot complications and chronic kidney disease (CKD).
View Article and Find Full Text PDFJ Med Biochem
November 2024
Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Tongji Shanxi Hospital, Department of Nephrology, Taiyuan, China.
Background: The paper aims to investigate the expression level of NLRP3 inflammasome and its related cell molecules in early diabetes kidney disease (EDKD) in the elderly and its clinical application value.
Methods: From October 2021 to April 2023, 50 elderly patients with T2DM (T2DM group), 50 elderly patients with EDKD (EDKD group) and 50 elderly people who passed the health check-up (healthy group) were chosen as the study subjects. Plasma NLRP3 inflammasome and related cells (blood leukocyte count, monocyte count, lymphocyte count) molecular (NT-proBNP and others) levels are tested, and Pearson correlation analysis is utilized to explore the correlation among plasma NLRP3 inflammasome and related cells, molecules, and renal function indicators (UACR, BUN, Ucr) in elderly patients with EDKD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!